Tag Archives: Other OTC:ARTH

Analysts Are Bullish on Top Healthcare Stocks: Arch Therapeutics (ARTH), Oragenics (OGEN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arch Therapeutics (ARTH – Research Report), Oragenics (OGEN – Research Report) and Seres Therapeutics (MCRB – Research Report) with bullish sentiments. Arch

Ladenburg Thalmann & Co. Reiterates a Buy Rating on Arch Therapeutics Inc (ARTH)

Ladenburg Thalmann & Co. analyst Michael Higgins reiterated a Buy rating on Arch Therapeutics Inc (ARTH – Research Report) on August 2 and set a price target of $1.25. The company’s shares closed on Friday at $0.28, close to its

Arch Therapeutics Inc (ARTH) Gets a Buy Rating from Ladenburg

In a report released today, Michael Higgins from Ladenburg reiterated a Buy rating on Arch Therapeutics Inc (ARTH – Research Report), with a price target of $1.25. The company’s shares closed yesterday at $0.28, close to its 52-week low of

H.C. Wainwright Sticks to Its Buy Rating for Arch Therapeutics Inc (ARTH)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Arch Therapeutics Inc (ARTH – Research Report) today and set a price target of $2.50. The company’s shares closed on Friday at $0.39. Selvaraju said: “Valuation methodology, risks and uncertainties.

Arch Therapeutics Inc Receives a Buy from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Arch Therapeutics Inc (Other OTC: ARTH), with a price target of $3. The company’s shares closed yesterday at $0.50. Selvaraju said: “Valuation methodology, risks and

H.C. Wainwright Keeps Their Buy Rating on Arch Therapeutics Inc

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Arch Therapeutics Inc (Other OTC: ARTH), with a price target of $3. The company’s shares closed yesterday at $0.66. Selvaraju wrote: “We consider this a